Responsibilities:
- Contribute to multi-disciplinary drug development/discovery with integrated understanding of DMPK properties, PK/PD, and DDI risk.
- Work in cross-functional teams to support clinical development and discovery across modalities.
- Design and interpret in silico, in vitro, and in vivo analyses to support therapeutics with desired DMPK profiles.
- Assess program risks (DDI, metabolism, translation) to guide clinical development.
- Author source reports and regulatory documents for filings; evaluate/predict program risks and implement strategies to address liabilities.
- Support discovery-to-clinic progression and efficient decision making; communicate clearly with development teams.
Qualifications:
- PhD or Masterβs in Pharmaceutical Sciences, Pharmacology, Chemistry, Biomedical Engineering, Biochemistry, or relevant life sciences.
- Masterβs with 12+ years relevant industry experience or PhD with 8+ years industry experience in discovery/development across modalities (small molecules, antibodies, drug conjugates).
- Demonstrated ability to represent DMPK in early-to-late clinical development (risk evaluation/mitigation, data integration, communication).
- Ability to drive DDI strategy and ensure timely risk assessment and clinical plans.
- Experience authoring documents for IB/IND/WMA filings and regulatory responses.
- Experience as a DMPK lead on discovery teams across modalities.